• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道神经内分泌肿瘤与妇科生殖道神经内分泌肿瘤——危险因素和非手术治疗疗效比较。

Neuroendocrine Neoplasms of the Gastrointestinal Tract versus Neuroendocrine Neoplasms of the Gynaecological Tract-Comparison of the Risk Factors and Non-Surgical Treatment Efficacy.

机构信息

Department of Reconstructive Surgery and Gynecological Oncology, Pomeranian Medical University in Szczecin, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.

Department of Obstetrics and Gynecology, Pomeranian Medical University in Szczecin, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.

出版信息

Int J Mol Sci. 2023 Apr 6;24(7):6853. doi: 10.3390/ijms24076853.

DOI:10.3390/ijms24076853
PMID:37047829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10095130/
Abstract

Neuroendocrine tumours of the gastrointestinal tract are rare. The incidence has increased in recent years due to improvements in diagnostic methods for detecting these lesions. These tumours have a poor prognosis, especially when detected at an advanced stage. The basis of the treatment is resection, and non-surgical treatments are also standard in the treatment process. The situation is similar in even rarer neuroendocrine tumours of the reproductive tract, which are associated with an equally poor prognosis. In this article, we focus on learning about the risk factors (including genetic mutations) that increase the risk of the disease and comparing the effectiveness of non-surgical treatments-chemotherapy, radiotherapy, peptide receptor radionuclide therapy, somatostatin analogues, and immunotherapy. The efficacy of these treatments varies, and immunotherapy appears to be a promising form of treatment; however, this requires further research.

摘要

胃肠道神经内分泌肿瘤较为罕见。近年来,由于这些病变的诊断方法有所改进,其发病率有所增加。这些肿瘤预后不良,尤其是在晚期发现时。治疗的基础是切除,非手术治疗也是治疗过程中的标准方法。在更为罕见的生殖系统神经内分泌肿瘤中也是如此,其预后同样较差。在本文中,我们重点学习了增加患病风险的危险因素(包括基因突变),并比较了非手术治疗方法(化疗、放疗、肽受体放射性核素治疗、生长抑素类似物和免疫疗法)的效果。这些治疗方法的效果各异,免疫疗法似乎是一种很有前途的治疗形式;然而,这需要进一步的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f40/10095130/07b9d01391c0/ijms-24-06853-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f40/10095130/3d637d2cc8bb/ijms-24-06853-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f40/10095130/07b9d01391c0/ijms-24-06853-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f40/10095130/3d637d2cc8bb/ijms-24-06853-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f40/10095130/07b9d01391c0/ijms-24-06853-g002.jpg

相似文献

1
Neuroendocrine Neoplasms of the Gastrointestinal Tract versus Neuroendocrine Neoplasms of the Gynaecological Tract-Comparison of the Risk Factors and Non-Surgical Treatment Efficacy.胃肠道神经内分泌肿瘤与妇科生殖道神经内分泌肿瘤——危险因素和非手术治疗疗效比较。
Int J Mol Sci. 2023 Apr 6;24(7):6853. doi: 10.3390/ijms24076853.
2
Neuroendocrine gastrointestinal tumours.神经内分泌胃肠道肿瘤
Ann Oncol. 1996 Jul;7(5):453-63. doi: 10.1093/oxfordjournals.annonc.a010633.
3
[Neuroendocrine tumours of pancreas and gastrointestinal tract].[胰腺和胃肠道神经内分泌肿瘤]
Klin Med (Mosk). 2009;87(12):7-13.
4
[Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system].[专家对话:肺和胃肠胰系统神经内分泌肿瘤]
Pneumologie. 2012 Jan;66(1):44-8. doi: 10.1055/s-0031-1291478. Epub 2012 Jan 16.
5
[Contemporary methods of diagnosis and treatment of neuroendocrine gastrointestinal tumors].[神经内分泌性胃肠肿瘤的当代诊断与治疗方法]
Endokrynol Pol. 2006 Mar-Apr;57(2):174-86.
6
[Neuroendocrine tumors of the gastrointestinal tract].[胃肠道神经内分泌肿瘤]
Praxis (Bern 1994). 2007 Jan 10;96(1-2):19-28. doi: 10.1024/1661-8157.96.1.19.
7
[Pathological implications in the neuroendocrine gastrointestinal system].[神经内分泌胃肠系统的病理意义]
Rev Med Liege. 2002 Aug;57(8):509-18.
8
Foreword: Gastroenteropancreatic system and its tumors: Part 2.前言:胃肠胰系统及其肿瘤:第2部分。
Endocrinol Metab Clin North Am. 2011 Mar;40(1):xiii-xv. doi: 10.1016/j.ecl.2011.01.002.
9
Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.神经内分泌胃肠胰腺肿瘤:ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii104-5. doi: 10.1093/annonc/mdn117.
10
[Gastrointestinal neuroendocrine tumors: update 2024].[胃肠道神经内分泌肿瘤:2024年更新]
Inn Med (Heidelb). 2024 Jul;65(7):664-671. doi: 10.1007/s00108-024-01734-y. Epub 2024 Jun 20.

引用本文的文献

1
Single-cell RNA sequencing highlights the unique tumor microenvironment of small cell neuroendocrine cervical carcinoma.单细胞RNA测序突显了宫颈小细胞神经内分泌癌独特的肿瘤微环境。
J Transl Med. 2025 Jan 6;23(1):19. doi: 10.1186/s12967-024-05977-z.

本文引用的文献

1
A case report of small cell ovarian neuroendocrine carcinoma combined with immunochemotherapy.小细胞卵巢神经内分泌癌合并免疫化疗病例报告。
Medicine (Baltimore). 2022 Nov 18;101(46):e31445. doi: 10.1097/MD.0000000000031445.
2
Evaluation of PD-L1 expression in a large set of gastroenteropancreatic neuroendocrine tumours and correlation with clinicopathological data.大量胃肠胰神经内分泌肿瘤中PD-L1表达的评估及其与临床病理数据的相关性
Transl Oncol. 2022 Nov;25:101526. doi: 10.1016/j.tranon.2022.101526. Epub 2022 Sep 5.
3
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial.
依托泊苷和顺铂与伊立替康和顺铂治疗消化系统晚期神经内分泌癌患者的疗效:TOPIC-NEC 阶段 3 随机临床试验。
JAMA Oncol. 2022 Oct 1;8(10):1447-1455. doi: 10.1001/jamaoncol.2022.3395.
4
Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma.伊匹单抗和纳武单抗用于复发性神经内分泌宫颈癌
Gynecol Oncol Rep. 2022 Jul 8;42:101039. doi: 10.1016/j.gore.2022.101039. eCollection 2022 Aug.
5
Sintilimab in Patients with Previously Treated Metastatic Neuroendocrine Neoplasms.信迪利单抗治疗经治转移性神经内分泌肿瘤患者的疗效
Oncologist. 2022 Aug 5;27(8):e625-e632. doi: 10.1093/oncolo/oyac097.
6
Neuroendocrine Neoplasms of the Gynecologic Tract.生殖道神经内分泌肿瘤
Cancers (Basel). 2022 Apr 6;14(7):1835. doi: 10.3390/cancers14071835.
7
Primary neuroendocrine tumors of the ovary: Management and outcomes.卵巢原发性神经内分泌肿瘤:治疗与预后。
Cancer Med. 2021 Dec;10(23):8558-8569. doi: 10.1002/cam4.4368. Epub 2021 Nov 12.
8
Complete Response to Combination Nivolumab and Ipilimumab in Recurrent Neuroendocrine Carcinoma of the Cervix.联合纳武单抗和伊匹单抗治疗复发性宫颈癌神经内分泌癌的完全缓解。
Obstet Gynecol. 2021 Nov 1;138(5):813-816. doi: 10.1097/AOG.0000000000004573.
9
Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results.高剂量兰瑞肽长效微球治疗进展性胰腺或中肠神经内分泌肿瘤的疗效和安全性:CLARINET FORTE 期 2 研究结果。
Eur J Cancer. 2021 Nov;157:403-414. doi: 10.1016/j.ejca.2021.06.056. Epub 2021 Sep 28.
10
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network.一线铂类依托泊苷治疗转移性神经内分泌癌的预后因素,重点关注 NEC 评分和 Rb 表达:来自 Groupe d'Etude des Tumeurs Endocrines (GTE) 和 ENDOCAN-RENATEN 网络的多中心 RBNEC 研究的结果。
Eur J Cancer. 2021 Jul;152:100-115. doi: 10.1016/j.ejca.2021.04.030. Epub 2021 Jun 3.